These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21701001)

  • 41. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging.
    Nishida S; Kinoshita H; Mishima T; Kurokawa H; Sakaida N; Matsuda T
    Int J Urol; 2011 Sep; 18(9):653-8. PubMed ID: 21790792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
    Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
    BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
    J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Robotic system for transrectal biopsy of the prostate: real-time guidance under MRI.
    Elhawary H; Tse ZT; Rea M; Zivanovic A; Davies BL; Besant C; de Souza NM; McRobbie D; Young I; Lampérth MU
    IEEE Eng Med Biol Mag; 2010; 29(2):78-86. PubMed ID: 20659844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V; Nosnik I; Sun L; Robertson CN; Walther P; Albala D; Moul JW; Polascik TJ
    Urology; 2007 Feb; 69(2):311-4. PubMed ID: 17320670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer.
    Nakashima J; Tanimoto A; Imai Y; Mukai M; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Urology; 2004 Jul; 64(1):101-5. PubMed ID: 15245944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
    Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
    Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and evaluation of an anatomically correct multi-image modality compatible phantom for prostate cancer focal ablation.
    Lindner U; Lawrentschuk N; Weersink RA; Raz O; Hlasny E; Sussman MS; Davidson SR; Gertner MR; Trachtenberg J
    J Urol; 2010 Jul; 184(1):352-7. PubMed ID: 20488477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.
    Sinnott M; Falzarano SM; Hernandez AV; Jones JS; Klein EA; Zhou M; Magi-Galluzzi C
    Prostate; 2012 Aug; 72(11):1179-86. PubMed ID: 22161896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contemporary appraisal of radical perineal prostatectomy.
    Janoff DM; Parra RO
    J Urol; 2005 Jun; 173(6):1863-70. PubMed ID: 15879765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical prostatectomy: value of prostate MRI in surgical planning.
    Tan N; Margolis DJ; McClure TD; Thomas A; Finley DS; Reiter RE; Huang J; Raman SS
    Abdom Imaging; 2012 Aug; 37(4):664-74. PubMed ID: 21993567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies.
    Siddiqui K; Chopra R; Vedula S; Sugar L; Haider M; Boyes A; Musquera M; Bronskill M; Klotz L
    Urology; 2010 Dec; 76(6):1506-11. PubMed ID: 20709381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Does transrectal MRI before radical prostatectomy modify the operative technique to decrease the positive margin rate?].
    Descazeaud A; Peyromaure M; Vieillefond A; Bernard D; Zerbib M
    Prog Urol; 2006 Nov; 16(5):564-7. PubMed ID: 17175952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.
    Sala E; Eberhardt SC; Akin O; Moskowitz CS; Onyebuchi CN; Kuroiwa K; Ishill N; Zelefsky MJ; Eastham JA; Hricak H
    Radiology; 2006 Jan; 238(1):176-83. PubMed ID: 16373766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
    Isebaert S; De Keyzer F; Haustermans K; Lerut E; Roskams T; Roebben I; Van Poppel H; Joniau S; Oyen R
    Eur J Radiol; 2012 Mar; 81(3):e217-22. PubMed ID: 21349667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.